Schedule 13G ownership disclosure
XORTX THERAPEUTICS INC
Common Shares, no par value per share · CUSIP: 98420Q306
Event date: 2025-10-23
- Filing-level shares
- 572,470.00
- Percent of class
- 9.9%
- Lincoln Alternative Strategies LLC
Shares: 572,470.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-019746
- Form type
- SCHEDULE 13G
- Filer
- Lincoln Alternative Strategies LLC
- CIK
- CIK 2043812
- Filed
- Oct 27, 2025
- Reporting period
- Oct 23, 2025
- Description
- Schedule 13G beneficial ownership